Exelixis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,147

Employees1,147

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,147

Employees1,147

EXEL Key Statistics

Market cap

12.42B

Market cap12.42B

Price-Earnings ratio

17.37

Price-Earnings ratio17.37

Dividend yield

—

Dividend yield—

Average volume

5.04M

Average volume5.04M

High today

$38.09

High today$38.09

Low today

$35.88

Low today$35.88

Open price

$36.19

Open price$36.19

Volume

5.59M

Volume5.59M

52 Week high

$49.62

52 Week high$49.62

52 Week low

$23.21

52 Week low$23.21

Analyst ratings

52%

of 21 ratings

Buy

52.4%

Hold

47.6%

Sell

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals

Sprouts Farmers Market